Carl Dambkowski
Chief Medical Officer; Director · 10 filings · Latest: Jun 22, 2026
Apogee Therapeutics, Inc.
Oruka Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | CARL DAMBKOWSKI | — | Jul 1, 2026 | Proposed Sale | $132.73 | 16,500 | $2.2M | — | |
APGE | Carl Dambkowski | Chief Medical Officer | Jun 22, 2026 | Sale | $132.60 | 26,400 | $3.5M | 179,248 | |
APGE | CARL DAMBKOWSKI | — | Jun 22, 2026 | Proposed Sale | $90.38 | 15,400 | $1.4M | — | |
ORKA | Carl Dambkowski | Director | Jun 12, 2026 | Sale | $70.11 | 12,583 | $882.2K | 38,743 | |
ORKA | Carl Dambkowski | Director | Jun 11, 2026 | Sale | $70.13 | 22,417 | $1.6M | 51,326 | |
ORKA | CARL DAMBKOWSKI | — | Jun 11, 2026 | Proposed Sale | $64.03 | 35,000 | $2.2M | — | |
APGE | Carl Dambkowski | Chief Medical Officer | Jun 3, 2026 | Sale | $78.71 | 5,500 | $432.9K | 205,648 | |
APGE | Carl Dambkowski | Chief Medical Officer | Jun 3, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 211,148 | |
ORKA | Carl Dambkowski | Director | May 21, 2026 | Sale | $58.97 | 105,000 | $6.2M | 73,743 | |
ORKA | Carl Dambkowski | Director | May 21, 2026 | Option Exercise | $7.95 | 62,260 | $494.8K | 178,743 | |
ORKA | CARL DAMBKOWSKI | — | May 21, 2026 | Proposed Sale | $60.67 | 105,000 | $6.4M | — | |
APGE | Carl Dambkowski | Chief Medical Officer | May 6, 2026 | Sale | $84.14 | 5,500 | $462.8K | 207,023 | |
APGE | Carl Dambkowski | Chief Medical Officer | May 6, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 212,523 | |
APGE | CARL DAMBKOWSKI | — | May 6, 2026 | Proposed Sale | $83.29 | 22,000 | $1.8M | — | |
APGE | Carl Dambkowski | Chief Medical Officer | Apr 1, 2026 | Sale | $84.84 | 5,500 | $466.6K | 208,398 | |
APGE | Carl Dambkowski | Chief Medical Officer | Apr 1, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 213,898 | |
APGE | Carl Dambkowski | Chief Medical Officer | Mar 4, 2026 | Sale | $71.06 | 5,500 | $390.8K | 209,773 | |
APGE | Carl Dambkowski | Chief Medical Officer | Mar 4, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 215,273 | |
APGE | Carl Dambkowski | Chief Medical Officer | Feb 4, 2026 | Sale | $65.79 | 5,500 | $361.9K | 211,148 | |
APGE | Carl Dambkowski | Chief Medical Officer | Feb 4, 2026 | Option Exercise | $22.86 | 4,125 | $94.3K | 216,648 |
Page 1 of 2
Next →